5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 97.68▲ | 97.26▲ | 97.01▲ | 96.54▲ | 90.71▲ |
MA10 | 97.44▲ | 96.80▲ | 96.62▲ | 93.60▲ | 79.36▲ |
MA20 | 97.31▲ | 96.54▲ | 97.04▲ | 90.17▲ | 69.94▲ |
MA50 | 96.84▲ | 96.64▲ | 94.43▲ | 78.60▲ | 60.88▲ |
MA100 | 96.53▲ | 94.06▲ | 90.87▲ | 69.13▲ | 50.18▲ |
MA200 | 96.97▲ | 90.42▲ | 89.17▲ | 62.82▲ | 33.56▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.036▲ | 0.123▲ | -0.100▼ | 0.202▲ | 3.155▲ |
RSI | 67.507▲ | 64.690▲ | 64.179▲ | 73.473▲ | 75.832▲ |
STOCH | 90.623▲ | 94.348▲ | 68.165 | 90.320▲ | 84.961▲ |
WILL %R | -10.989▲ | -4.878▲ | -4.878▲ | -9.495▲ | -3.270▲ |
CCI | 89.631 | 152.389▲ | 200.486▲ | 110.566▲ | 113.134▲ |
Thursday, August 07, 2025 04:07 AM
NasdaqGM:RYTM 1 Year Share Price vs Fair Value Explore Rhythm Pharmaceuticals's Fair Values from the Community ...
|
Tuesday, August 05, 2025 04:13 AM
Second quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $48.5 million -- -- U.S. and EU regulatory submissions for setmelanotide in acquired hypothalamic obesity on ...
|
Friday, August 01, 2025 03:59 AM
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 28, Whitney Ijem from Canaccord Genuity maintained a Buy rating on Rhythm ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 96.65 | 97.795 | 95.80 | 97.61 | 522,267 |
14/08/25 | 96.86 | 97.545 | 95.3002 | 96.48 | 583,771 |
13/08/25 | 96.00 | 99.04 | 95.762 | 97.86 | 733,613 |
12/08/25 | 94.19 | 96.65 | 93.55 | 96.46 | 538,703 |
11/08/25 | 90.27 | 94.39 | 89.2077 | 94.31 | 626,069 |
08/08/25 | 92.24 | 93.71 | 90.48 | 91.98 | 819,643 |
07/08/25 | 89.51 | 92.48 | 88.00 | 92.48 | 557,491 |
06/08/25 | 87.99 | 90.985 | 87.99 | 90.01 | 639,226 |
05/08/25 | 87.19 | 90.09 | 85.73 | 88.57 | 674,604 |
04/08/25 | 88.47 | 90.40 | 87.16 | 90.24 | 624,938 |
|
|
||||
|
|
||||
|
|